Dhanalaxmi Roto Spinners Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 11:16 am

Competitors of Dhanalaxmi Roto Spinners Ltd

All Competitor Stocks of Dhanalaxmi Roto Spinners Ltd

Quarterly Result

Last Updated: August 19, 2025, 8:10 pm

Below is a detailed analysis of the quarterly data for Dhanalaxmi Roto Spinners Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 79.65 Cr.. The value appears strong and on an upward trend. It has increased from 41.58 Cr. (Mar 2025) to 79.65 Cr., marking an increase of 38.07 Cr..
• For Expenses, as of Jun 2025, the value is 77.62 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 39.20 Cr. (Mar 2025) to 77.62 Cr., marking an increase of 38.42 Cr..
• For Operating Profit, as of Jun 2025, the value is 2.03 Cr.. The value appears to be declining and may need further review. It has decreased from 2.38 Cr. (Mar 2025) to 2.03 Cr., marking a decrease of 0.35 Cr..
• For OPM %, as of Jun 2025, the value is 2.55%. The value appears to be declining and may need further review. It has decreased from 5.72% (Mar 2025) to 2.55%, marking a decrease of 3.17%.
• For Other Income, as of Jun 2025, the value is 1.63 Cr.. The value appears to be declining and may need further review. It has decreased from 3.04 Cr. (Mar 2025) to 1.63 Cr., marking a decrease of 1.41 Cr..
• For Interest, as of Jun 2025, the value is 0.27 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.31 Cr. (Mar 2025) to 0.27 Cr., marking a decrease of 0.04 Cr..
• For Depreciation, as of Jun 2025, the value is 0.06 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.03 Cr. (Mar 2025) to 0.06 Cr., marking an increase of 0.03 Cr..
• For Profit before tax, as of Jun 2025, the value is 3.33 Cr.. The value appears to be declining and may need further review. It has decreased from 5.08 Cr. (Mar 2025) to 3.33 Cr., marking a decrease of 1.75 Cr..
• For Tax %, as of Jun 2025, the value is 26.13%. The value appears to be improving (decreasing) as expected. It has decreased from 27.36% (Mar 2025) to 26.13%, marking a decrease of 1.23%.
• For Net Profit, as of Jun 2025, the value is 2.47 Cr.. The value appears to be declining and may need further review. It has decreased from 3.69 Cr. (Mar 2025) to 2.47 Cr., marking a decrease of 1.22 Cr..
• For EPS in Rs, as of Jun 2025, the value is 3.17. The value appears to be declining and may need further review. It has decreased from 4.73 (Mar 2025) to 3.17, marking a decrease of 1.56.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 3:31 am

Growth

Last Updated: September 5, 2025, 3:11 pm

Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Dhanalaxmi Roto Spinners Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 10.95. This value is within the healthy range. It has decreased from 33.52 (Mar 24) to 10.95, marking a decrease of 22.57.
• For Diluted EPS (Rs.), as of Mar 25, the value is 10.95. This value is within the healthy range. It has decreased from 33.52 (Mar 24) to 10.95, marking a decrease of 22.57.
• For Cash EPS (Rs.), as of Mar 25, the value is 11.28. This value is within the healthy range. It has decreased from 34.29 (Mar 24) to 11.28, marking a decrease of 23.01.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 71.63. It has decreased from 125.51 (Mar 24) to 71.63, marking a decrease of 53.88.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 72.95. It has decreased from 125.51 (Mar 24) to 72.95, marking a decrease of 52.56.
• For Dividend / Share (Rs.), as of Mar 25, the value is 1.50. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.50.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 237.76. It has decreased from 504.07 (Mar 24) to 237.76, marking a decrease of 266.31.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 16.41. This value is within the healthy range. It has decreased from 44.59 (Mar 24) to 16.41, marking a decrease of 28.18.
• For PBIT / Share (Rs.), as of Mar 25, the value is 16.08. This value is within the healthy range. It has decreased from 43.82 (Mar 24) to 16.08, marking a decrease of 27.74.
• For PBT / Share (Rs.), as of Mar 25, the value is 14.82. This value is within the healthy range. It has decreased from 44.88 (Mar 24) to 14.82, marking a decrease of 30.06.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 10.95. This value is within the healthy range. It has decreased from 33.52 (Mar 24) to 10.95, marking a decrease of 22.57.
• For PBDIT Margin (%), as of Mar 25, the value is 6.90. This value is below the healthy minimum of 10. It has decreased from 8.84 (Mar 24) to 6.90, marking a decrease of 1.94.
• For PBIT Margin (%), as of Mar 25, the value is 6.76. This value is below the healthy minimum of 10. It has decreased from 8.69 (Mar 24) to 6.76, marking a decrease of 1.93.
• For PBT Margin (%), as of Mar 25, the value is 6.23. This value is below the healthy minimum of 10. It has decreased from 8.90 (Mar 24) to 6.23, marking a decrease of 2.67.
• For Net Profit Margin (%), as of Mar 25, the value is 4.60. This value is below the healthy minimum of 5. It has decreased from 6.64 (Mar 24) to 4.60, marking a decrease of 2.04.
• For Return on Networth / Equity (%), as of Mar 25, the value is 15.28. This value is within the healthy range. It has decreased from 26.70 (Mar 24) to 15.28, marking a decrease of 11.42.
• For Return on Capital Employeed (%), as of Mar 25, the value is 21.68. This value is within the healthy range. It has decreased from 34.27 (Mar 24) to 21.68, marking a decrease of 12.59.
• For Return On Assets (%), as of Mar 25, the value is 9.39. This value is within the healthy range. It has decreased from 16.20 (Mar 24) to 9.39, marking a decrease of 6.81.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.11. This value is within the healthy range. It has increased from 0.02 (Mar 24) to 0.11, marking an increase of 0.09.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 2.16. It has decreased from 2.79 (Mar 24) to 2.16, marking a decrease of 0.63.
• For Current Ratio (X), as of Mar 25, the value is 2.51. This value is within the healthy range. It has increased from 2.45 (Mar 24) to 2.51, marking an increase of 0.06.
• For Quick Ratio (X), as of Mar 25, the value is 2.18. This value exceeds the healthy maximum of 2. It has decreased from 2.43 (Mar 24) to 2.18, marking a decrease of 0.25.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 31.14. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 31.14, marking an increase of 31.14.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 6.84. This value is below the healthy minimum of 20. It has increased from 3.72 (Mar 24) to 6.84, marking an increase of 3.12.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 6.64. This value is below the healthy minimum of 20. It has increased from 3.64 (Mar 24) to 6.64, marking an increase of 3.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 93.16. This value exceeds the healthy maximum of 70. It has decreased from 96.28 (Mar 24) to 93.16, marking a decrease of 3.12.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 93.36. This value exceeds the healthy maximum of 70. It has decreased from 96.36 (Mar 24) to 93.36, marking a decrease of 3.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 13.15. This value is within the healthy range. It has decreased from 20.15 (Mar 24) to 13.15, marking a decrease of 7.00.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 9.78. This value is within the healthy range. It has decreased from 14.67 (Mar 24) to 9.78, marking a decrease of 4.89.
• For Enterprise Value (Cr.), as of Mar 25, the value is 73.78. It has increased from 30.53 (Mar 24) to 73.78, marking an increase of 43.25.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.39. This value is below the healthy minimum of 1. It has increased from 0.15 (Mar 24) to 0.39, marking an increase of 0.24.
• For EV / EBITDA (X), as of Mar 25, the value is 5.76. This value is within the healthy range. It has increased from 1.76 (Mar 24) to 5.76, marking an increase of 4.00.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 1. It has increased from 0.34 (Mar 24) to 0.46, marking an increase of 0.12.
• For Retention Ratios (%), as of Mar 25, the value is 93.15. This value exceeds the healthy maximum of 70. It has decreased from 96.27 (Mar 24) to 93.15, marking a decrease of 3.12.
• For Price / BV (X), as of Mar 25, the value is 1.56. This value is within the healthy range. It has increased from 1.39 (Mar 24) to 1.56, marking an increase of 0.17.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 1. It has increased from 0.34 (Mar 24) to 0.46, marking an increase of 0.12.
• For EarningsYield, as of Mar 25, the value is 0.09. This value is below the healthy minimum of 5. It has decreased from 0.19 (Mar 24) to 0.09, marking a decrease of 0.10.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness